We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+26.7%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.63B
AUM Growth
-$51.2M
Cap. Flow
-$796M
Cap. Flow %
-21.94%
Top 10 Hldgs %
59.45%
Holding
54
New
11
Increased
8
Reduced
25
Closed
10

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$118M
2
MAR icon
Marriott International
MAR
+$62.7M
3
DVA icon
DaVita
DVA
+$61.5M
4
DGX icon
Quest Diagnostics
DGX
+$57.9M
5
UHS icon
Universal Health Services
UHS
+$32.4M

Top Sells

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$158M
2
FLEX icon
Flex
FLEX
+$98.4M
3
HOLX
Hologic
HOLX
+$96.9M
4
FMC icon
FMC
FMC
+$73.4M
5
HCA icon
HCA Healthcare
HCA
+$68.1M

Sector Composition

Rank Sector Weight
1 Healthcare 70.3%
2 Technology 9.78%
3 Consumer Discretionary 6.74%
4 Materials 5.97%
5 Communication Services 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
1
Tenet Healthcare
THC
$21.1B
$358M 9.87%
19,761,353
+25,728
+0.1% +$507K
TAK icon
2
Takeda Pharmaceutical
TAK
$55.7B
$290M 8.01%
16,195,310
-3,761,689
-19% -$67.5M
BHC icon
3
Bausch Health
BHC
$2.34B
$286M 7.89%
15,644,128
-972,880
-6% -$17.1M
CI icon
4
Cigna
CI
$74.6B
$244M 6.73%
1,301,750
-166,009
-11% -$31.5M
HCA icon
5
HCA Healthcare
HCA
$89.5B
$209M 5.77%
2,157,209
-655,472
-23% -$68.1M
DXC icon
6
DXC Technology
DXC
$1.73B
$198M 5.45%
11,988,030
+1,001,468
+9% +$15.9M
MCK icon
7
McKesson
MCK
$101B
$187M 5.15%
1,218,704
-423,430
-26% -$61.2M
PARA
8
DELISTED
Paramount Global Class B
PARA
$134M 3.7%
5,756,784
-3,527,805
-38% -$68M
NUAN
9
DELISTED
Nuance Communications, Inc.
NUAN
$128M 3.52%
5,042,131
-1,070,604
-18% -$22.4M
LH icon
10
Labcorp
LH
$25.9B
$122M 3.36%
+854,427
New +$118M
FMC icon
11
FMC
FMC
$1.33B
$114M 3.15%
1,147,119
-795,594
-41% -$73.4M
HOLX
12
DELISTED
Hologic
HOLX
$110M 3.04%
1,935,735
-1,974,845
-51% -$96.9M
MTOR
13
DELISTED
MERITOR, Inc.
MTOR
$108M 2.98%
5,451,480
-1,755,955
-24% -$32.4M
COR icon
14
Cencora
COR
$61.2B
$96.3M 2.65%
955,159
+217,159
+29% +$20M
IQV icon
15
IQVIA
IQV
$39.3B
$78.2M 2.16%
551,258
-1,163,075
-68% -$158M
BSX icon
16
Boston Scientific
BSX
$71.5B
$74.2M 2.05%
2,113,001
-274,858
-12% -$9.9M
CTVA icon
17
Corteva
CTVA
$51.3B
$67.5M 1.86%
2,517,740
+1,101,178
+78% +$28.7M
HUM icon
18
Humana
HUM
$46.2B
$66.4M 1.83%
171,332
-164,613
-49% -$61.6M
UHS icon
19
Universal Health Services
UHS
$10.5B
$63M 1.74%
678,152
+323,777
+91% +$32.4M
DVA icon
20
DaVita
DVA
$11.7B
$62.3M 1.72%
+787,483
New +$61.5M
DGX icon
21
Quest Diagnostics
DGX
$26.3B
$62.2M 1.72%
+546,061
New +$57.9M
MAR icon
22
Marriott International
MAR
$92.3B
$61.9M 1.71%
+721,889
New +$62.7M
MOH icon
23
Molina Healthcare
MOH
$10.3B
$59.1M 1.63%
332,019
+53,317
+19% +$9.08M
CAR icon
24
Avis
CAR
$5.02B
$52.1M 1.44%
2,275,409
-1,069,167
-32% -$19.6M
URI icon
25
United Rentals
URI
$72.4B
$48.2M 1.33%
323,316
-72,267
-18% -$9.17M
1
2 3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return

Glenview Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Glenview Capital Management held 54 positions worth $3.63B, down 1.4% from $3.68B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Glenview Capital Management withdrew a net $796M in Q2 2020, closing 10 positions and reducing 25 holdings. Its most notable exit was Flex, an estimated $98.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 69% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Glenview Capital Management opened a new position in Labcorp worth $122M.

  • Glenview Capital Management's largest Q2 2020 buy was Labcorp: 854,427 shares worth $122M.
  • Glenview Capital Management added most to Universal Health Services in Q2 2020, an estimated $32.4M increase.
  • Glenview Capital Management's biggest Q2 2020 reduction was IQVIA, cutting an estimated $158M.
  • Glenview Capital Management fully exited Flex in Q2 2020, selling an estimated $98.4M.
  • Glenview Capital Management's ten largest holdings make up 59% of its $3.63B portfolio in Q2 2020.
  • Glenview Capital Management opened 11 new positions and closed 10 in Q2 2020.
  • Glenview Capital Management's portfolio value fell 1.4% quarter-over-quarter to $3.63B.

Based on Glenview Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.